Metaxalone Tablet
NDC 72789-028
Product Information
Metaxalone is a ANDA-approved product labeled by Pd-rx Pharmaceuticals, Inc.. Metaxalone is used to treat muscle spasms/pain. It is supplied as a pink tablet for oral administration. This product entry covers the primary NDC 72789-028 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
SG;323
Code Structure Chart
Product Details
What is NDC 72789-028?
What are the uses of this product?
What are Active Ingredients of this product?
- METAXALONE 800 mg/1 - muscle spasm relaxant; structure
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- METAXALONE (UNII: 1NMA9J598Y)
- METAXALONE (UNII: 1NMA9J598Y) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ALGINIC ACID (UNII: 8C3Z4148WZ)
- STARCH, CORN (UNII: O8232NY3SJ)
- FERRIC OXIDE RED (UNII: 1K09F3G675)
- COPOVIDONE K25-31 (UNII: D9C330MD8B)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- POVIDONE, UNSPECIFIED (UNII: FZ989GH94E)
- SODIUM ALGINATE (UNII: C269C4G2ZQ)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 351254 - metaxalone 800 MG Oral Tablet
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.
Patient Education
Metaxalone
Metaxalone, a muscle relaxant, is used with rest, physical therapy, and other measures to relax muscles and relieve pain and discomfort caused by strains, sprains, and other muscle injuries.
[Learn More]
* Please review the full disclaimer at the bottom of this page.